Ciao3 knockout causes acute lung injury through immune activation using single cell sequencing

Jie Peng1, Chunying Wang1, Ting Liu1

  • 1School of Clinical Medicine, the First Affiliated Hospital of Chengdu Medical College, Chengdu, Sichuan Province, 610500, PR China.

Life Sciences
|November 4, 2025
PubMed
Abstract

Insights

Ciao3 knockout in mice triggers a cytokine storm and acute lung injury (ALI) by activating immune cells, particularly monocytes and macrophages. Inhibiting TNF-α can reverse these effects, suggesting a therapeutic target for lung inflammation.

Area of Science:

  • Vascular Biology
  • Immunology
  • Genetics

Background:

  • The CIAO3 mutation is linked to diffuse pulmonary arteriovenous malformations (dPAVMs).
  • A patient with a CIAO3 mutation experienced a cytokine storm.
  • This study investigates the role of CIAO3 in endothelial cells (ECs).

Purpose of the Study:

  • To clarify the potential roles of CIAO3 in endothelial cells.
  • To investigate the link between CIAO3 mutation, cytokine storm, and acute lung injury (ALI).
  • To identify the immune cells and pathways involved in CIAO3-related lung pathology.

Main Methods:

  • Conditional knockout of Ciao3 in mouse endothelial cells (EC-CKO).
  • Cytokine level measurement, bulk and single-cell RNA sequencing (RNA-seq, scRNA-seq).
  • Bioinformatic analyses including differential gene expression, pathway enrichment, protein-protein interaction, and cell communication analysis.

Main Results:

  • Ciao3 knockout in mice led to increased cytokine levels and acute lung injury (ALI), indicative of immune activation.
  • Tumor necrosis factor-alpha (TNF-α) inhibition reversed ALI, confirming inflammatory activation as the cause.
  • scRNA-seq revealed altered immune cell populations and abnormal EC-immune cell communication, with monocytes and macrophages identified as key effectors.
  • Upregulation of CypA and macrophage infiltration were confirmed via immunohistochemistry.

Conclusions:

  • Ciao3 knockout induces ALI in mice through immune activation.
  • Monocytes and macrophages are central effectors in this process.
  • Targeting these immune cells or related pathways may offer therapeutic strategies for CIAO3-associated lung diseases.

Related Concept Videos